RapidAI Scores FDA Clearance, Bringing AI-Powered Stroke Assessment to the Interventional Suite

Maze files for first biotech IPO of 2025, following $115M funding boost

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

January 8, 2025

Review of the Psychedelic Industry in 2023: A Year of Toil, Torment, and Triumph | Psychedelic Invest

2023— the year that everyone in the psychedelic industry prepared for takeoff. Well, theoretical (but probable) take off. And, just a few weeks before 2023

January 19, 2024

Laughter is as good as eye drops in soothing dry eyes, study finds

A study reveals laughter exercise is as effective as artificial tears for dry eye disease, improving symptoms and tear film stability without adverse effects.

September 16, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.